Company
Headquarters: Zhubei, Taiwan
CEO: Mr. Ih-Houng Loh
TW$4.70 Billion
TWD as of Jan. 1, 2024
US$153.1 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive Surgical, Inc. | $113.81 B |
| EssilorLuxottica SA | $90.57 B |
| Becton, Dickinson and Company | $70.33 B |
| HOYA Corp | $43.39 B |
| Alcon Inc. | $37.65 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company provides nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices; intraocular lenses for the treatment of cataracts, myopia, hyperopia, presbyopia, or astigmatism; and related technical services. It has operations in the United States, England, Japan, Taiwan, Spain, Korea, Hungary, Israel, China, and internationally. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
ICARES Medicus, Inc. has the following listings and related stock indices.
Stock: TWSE: 6612 wb_incandescent